201 related articles for article (PubMed ID: 38658617)
1. Single-cell RNA sequencing reveals the cellular and molecular heterogeneity of treatment-naïve primary osteosarcoma in dogs.
Ammons DT; Hopkins LS; Cronise KE; Kurihara J; Regan DP; Dow S
Commun Biol; 2024 Apr; 7(1):496. PubMed ID: 38658617
[TBL] [Abstract][Full Text] [Related]
2. Single-cell RNA sequencing reveals the cellular and molecular heterogeneity of treatment-naïve primary osteosarcoma in dogs.
Ammons D; Hopkins L; Cronise K; Kurihara J; Regan D; Dow S
Res Sq; 2023 Aug; ():. PubMed ID: 37609233
[TBL] [Abstract][Full Text] [Related]
3. Comparative Immunogenomics of Canine Natural Killer Cells as Immunotherapy Target.
Gingrich AA; Reiter TE; Judge SJ; York D; Yanagisawa M; Razmara A; Sturgill I; Basmaci UN; Brady RV; Stoffel K; Murphy WJ; Rebhun RB; Brown CT; Canter RJ
Front Immunol; 2021; 12():670309. PubMed ID: 34594320
[TBL] [Abstract][Full Text] [Related]
4. A single-cell RNA sequencing atlas of circulating leukocytes from healthy and osteosarcoma affected dogs.
Ammons DT; Harris RA; Hopkins LS; Kurihara J; Weishaar K; Dow S
Front Immunol; 2023; 14():1162700. PubMed ID: 37275879
[TBL] [Abstract][Full Text] [Related]
5. Single-Nuclei Multiome (ATAC + Gene Expression) Sequencing of a Primary Canine Osteosarcoma Elucidates Intra-Tumoral Heterogeneity and Characterizes the Tumor Microenvironment.
Nance RL; Wang X; Sandey M; Matz BM; Thomas A; Smith BF
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003552
[TBL] [Abstract][Full Text] [Related]
6. Global gene expression analysis of canine osteosarcoma stem cells reveals a novel role for COX-2 in tumour initiation.
Pang LY; Gatenby EL; Kamida A; Whitelaw BA; Hupp TR; Argyle DJ
PLoS One; 2014; 9(1):e83144. PubMed ID: 24416158
[TBL] [Abstract][Full Text] [Related]
7. Comparative biology of human and canine osteosarcoma.
Mueller F; Fuchs B; Kaser-Hotz B
Anticancer Res; 2007; 27(1A):155-64. PubMed ID: 17352227
[TBL] [Abstract][Full Text] [Related]
8. Novel application of single-cell next-generation sequencing for determination of intratumoral heterogeneity of canine osteosarcoma cell lines.
Ayers J; Milner RJ; Cortés-Hinojosa G; Riva A; Bechtel S; Sahay B; Cascio M; Lejeune A; Shiomitsu K; Souza C; Hernandez O; Salute M
J Vet Diagn Invest; 2021 Mar; 33(2):261-278. PubMed ID: 33446089
[TBL] [Abstract][Full Text] [Related]
9. MiR-9 is overexpressed in spontaneous canine osteosarcoma and promotes a metastatic phenotype including invasion and migration in osteoblasts and osteosarcoma cell lines.
Fenger JM; Roberts RD; Iwenofu OH; Bear MD; Zhang X; Couto JI; Modiano JF; Kisseberth WC; London CA
BMC Cancer; 2016 Oct; 16(1):784. PubMed ID: 27724924
[TBL] [Abstract][Full Text] [Related]
10. Tumor suppressor PTEN is mutated in canine osteosarcoma cell lines and tumors.
Levine RA; Forest T; Smith C
Vet Pathol; 2002 May; 39(3):372-8. PubMed ID: 12014501
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the effects of M2 macrophage-derived PDE4C on the prognosis, metastasis and immunotherapy benefit of osteosarcoma.
Pan F; Pan R; Hu R; Zhang H; Lei S; Zhang L; Zhou C; Zeng Z; Tian X; Xie Q
J Cell Mol Med; 2024 May; 28(10):e18395. PubMed ID: 38774995
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive analysis of prognostic tumor microenvironment-related genes in osteosarcoma patients.
Hu C; Liu C; Tian S; Wang Y; Shen R; Rao H; Li J; Yang X; Chen B; Ye L
BMC Cancer; 2020 Aug; 20(1):814. PubMed ID: 32854645
[TBL] [Abstract][Full Text] [Related]
13. Tumor-associated macrophages in osteosarcoma.
Zhao Y; Zhang B; Zhang Q; Ma X; Feng H
J Zhejiang Univ Sci B; 2021 Nov; 22(11):885-892. PubMed ID: 34783219
[TBL] [Abstract][Full Text] [Related]
14. Characterization of canine osteosarcoma by array comparative genomic hybridization and RT-qPCR: signatures of genomic imbalance in canine osteosarcoma parallel the human counterpart.
Angstadt AY; Motsinger-Reif A; Thomas R; Kisseberth WC; Guillermo Couto C; Duval DL; Nielsen DM; Modiano JF; Breen M
Genes Chromosomes Cancer; 2011 Nov; 50(11):859-74. PubMed ID: 21837709
[TBL] [Abstract][Full Text] [Related]
15. Immune pathways and TP53 missense mutations are associated with longer survival in canine osteosarcoma.
Das S; Idate R; Regan DP; Fowles JS; Lana SE; Thamm DH; Gustafson DL; Duval DL
Commun Biol; 2021 Oct; 4(1):1178. PubMed ID: 34635775
[TBL] [Abstract][Full Text] [Related]
16. Characterisation of complex karyotype changes in two canine bone tumours.
Mayr B; Eschborn U; Loupal G; Schleger W
Res Vet Sci; 1991 Nov; 51(3):341-3. PubMed ID: 1780594
[TBL] [Abstract][Full Text] [Related]
17. Canine osteosarcoma checkpoint expression correlates with metastasis and T-cell infiltrate.
Cascio MJ; Whitley EM; Sahay B; Cortes-Hinojosa G; Chang LJ; Cowart J; Salute M; Sayour E; Dark M; Sandoval Z; Mitchell DA; Milner RJ
Vet Immunol Immunopathol; 2021 Feb; 232():110169. PubMed ID: 33387703
[TBL] [Abstract][Full Text] [Related]
18. Cancer-associated mesenchymal stroma fosters the stemness of osteosarcoma cells in response to intratumoral acidosis via NF-κB activation.
Avnet S; Di Pompo G; Chano T; Errani C; Ibrahim-Hashim A; Gillies RJ; Donati DM; Baldini N
Int J Cancer; 2017 Mar; 140(6):1331-1345. PubMed ID: 27888521
[TBL] [Abstract][Full Text] [Related]
19. Pre- and postoperative studies of in vitro cell-mediated reactivity in canine osteosarcoma.
Bech-Nielsen S; Reif JS; Brodey RS
Am J Vet Res; 1978 Jan; 39(1):87-93. PubMed ID: 272858
[No Abstract] [Full Text] [Related]
20. Comparative Immunology and Immunotherapy of Canine Osteosarcoma.
Mason NJ
Adv Exp Med Biol; 2020; 1258():199-221. PubMed ID: 32767244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
